Clinical Data, Inc. Announces Purchase of Protedyne's Radius Automation System to Increase Sequencing Throughput, Lab Efficiencies and Cost Reductions  
3/12/2007 12:33:34 PM

NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) announced today that its Cogenics Division, a leading provider of pharmacogenomics and molecular biology services, has chosen the Radius automation system produced by Protedyne Corporation to increase throughput and capacity to meet the needs of its growing client base in its Quantitative PCR and CLIA sequencing offerings.